The cyclin D1 gene, located on chromosome 11q13, is frequently rearran
ged in parathyroid neoplasms and amplified in some carcinomas of other
organs. Recent studies have detected amplification of cyclin D1 and o
ther markers on chromosome 11q13 (evaluated by Southern or slot blot a
ssays) in similar to 25-50% of squamous cell carcinomas of the esophag
us and noted that amplification was associated with lessened survival
time. We applied the technique of differential polymerase chain reacti
on to the evaluation of cyclin D1 gene amplification in squamous cell
carcinomas of the esophagus. Cyclin D1 was found to be amplified in 10
of 45 (22%) primary tumors and three of 12 (25%) lymph node metastase
s. Lymph node metastases tended to be more common in patients with cyc
lin D1 amplification (70%) than in those without amplification (37%).
In 36 patients with follow-up, cyclin D1 amplification was associated
with decreased 1 year survival (28% vs. 59%). Cyclin D1 gene amplifica
tion in esophageal carcinomas can be evaluated by differential polymer
ase chain reaction and may provide useful prognostic information.